Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Opioid Use Disorder Revenue 1.4 Market Analysis by Type 1.4.1 Global Opioid Use Disorder Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Buprenorphine 1.4.3 Methadone 1.4.4 Naltrexone 1.5 Market by Application 1.5.1 Global Opioid Use Disorder Market Share by Application: 2020 VS 2026 1.5.2 Moderate Pain Treatment 1.5.3 Severe Pain Treatment 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Opioid Use Disorder Market Perspective (2015-2026) 2.2 Opioid Use Disorder Growth Trends by Regions 2.2.1 Opioid Use Disorder Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Opioid Use Disorder Historic Market Share by Regions (2015-2020) 2.2.3 Opioid Use Disorder Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Opioid Use Disorder Market Growth Strategy 2.3.6 Primary Interviews with Key Opioid Use Disorder Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Opioid Use Disorder Players by Market Size 3.1.1 Global Top Opioid Use Disorder Players by Revenue (2015-2020) 3.1.2 Global Opioid Use Disorder Revenue Market Share by Players (2015-2020) 3.1.3 Global Opioid Use Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Opioid Use Disorder Market Concentration Ratio 3.2.1 Global Opioid Use Disorder Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Opioid Use Disorder Revenue in 2019 3.3 Opioid Use Disorder Key Players Head office and Area Served 3.4 Key Players Opioid Use Disorder Product Solution and Service 3.5 Date of Enter into Opioid Use Disorder Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Opioid Use Disorder Historic Market Size by Type (2015-2020) 4.2 Global Opioid Use Disorder Forecasted Market Size by Type (2021-2026) 5 Opioid Use Disorder Breakdown Data by Application (2015-2026) 5.1 Global Opioid Use Disorder Market Size by Application (2015-2020) 5.2 Global Opioid Use Disorder Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Opioid Use Disorder Market Size (2015-2020) 6.2 Opioid Use Disorder Key Players in North America (2019-2020) 6.3 North America Opioid Use Disorder Market Size by Type (2015-2020) 6.4 North America Opioid Use Disorder Market Size by Application (2015-2020) 7 Europe 7.1 Europe Opioid Use Disorder Market Size (2015-2020) 7.2 Opioid Use Disorder Key Players in Europe (2019-2020) 7.3 Europe Opioid Use Disorder Market Size by Type (2015-2020) 7.4 Europe Opioid Use Disorder Market Size by Application (2015-2020) 8 China 8.1 China Opioid Use Disorder Market Size (2015-2020) 8.2 Opioid Use Disorder Key Players in China (2019-2020) 8.3 China Opioid Use Disorder Market Size by Type (2015-2020) 8.4 China Opioid Use Disorder Market Size by Application (2015-2020) 9 Japan 9.1 Japan Opioid Use Disorder Market Size (2015-2020) 9.2 Opioid Use Disorder Key Players in Japan (2019-2020) 9.3 Japan Opioid Use Disorder Market Size by Type (2015-2020) 9.4 Japan Opioid Use Disorder Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Opioid Use Disorder Market Size (2015-2020) 10.2 Opioid Use Disorder Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Opioid Use Disorder Market Size by Type (2015-2020) 10.4 Southeast Asia Opioid Use Disorder Market Size by Application (2015-2020) 11 India 11.1 India Opioid Use Disorder Market Size (2015-2020) 11.2 Opioid Use Disorder Key Players in India (2019-2020) 11.3 India Opioid Use Disorder Market Size by Type (2015-2020) 11.4 India Opioid Use Disorder Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Opioid Use Disorder Market Size (2015-2020) 12.2 Opioid Use Disorder Key Players in Central & South America (2019-2020) 12.3 Central & South America Opioid Use Disorder Market Size by Type (2015-2020) 12.4 Central & South America Opioid Use Disorder Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Indivior 13.1.1 Indivior Company Details 13.1.2 Indivior Business Overview and Its Total Revenue 13.1.3 Indivior Opioid Use Disorder Introduction 13.1.4 Indivior Revenue in Opioid Use Disorder Business (2015-2020)) 13.1.5 Indivior Recent Development 13.2 Alkermes 13.2.1 Alkermes Company Details 13.2.2 Alkermes Business Overview and Its Total Revenue 13.2.3 Alkermes Opioid Use Disorder Introduction 13.2.4 Alkermes Revenue in Opioid Use Disorder Business (2015-2020) 13.2.5 Alkermes Recent Development 13.3 Titan Pharmaceuticals 13.3.1 Titan Pharmaceuticals Company Details 13.3.2 Titan Pharmaceuticals Business Overview and Its Total Revenue 13.3.3 Titan Pharmaceuticals Opioid Use Disorder Introduction 13.3.4 Titan Pharmaceuticals Revenue in Opioid Use Disorder Business (2015-2020) 13.3.5 Titan Pharmaceuticals Recent Development 13.4 Hikma Pharmaceuticals 13.4.1 Hikma Pharmaceuticals Company Details 13.4.2 Hikma Pharmaceuticals Business Overview and Its Total Revenue 13.4.3 Hikma Pharmaceuticals Opioid Use Disorder Introduction 13.4.4 Hikma Pharmaceuticals Revenue in Opioid Use Disorder Business (2015-2020) 13.4.5 Hikma Pharmaceuticals Recent Development 13.5 Teva Pharmaceuticals 13.5.1 Teva Pharmaceuticals Company Details 13.5.2 Teva Pharmaceuticals Business Overview and Its Total Revenue 13.5.3 Teva Pharmaceuticals Opioid Use Disorder Introduction 13.5.4 Teva Pharmaceuticals Revenue in Opioid Use Disorder Business (2015-2020) 13.5.5 Teva Pharmaceuticals Recent Development 13.6 MediciNova 13.6.1 MediciNova Company Details 13.6.2 MediciNova Business Overview and Its Total Revenue 13.6.3 MediciNova Opioid Use Disorder Introduction 13.6.4 MediciNova Revenue in Opioid Use Disorder Business (2015-2020) 13.6.5 MediciNova Recent Development 13.7 Orexo 13.7.1 Orexo Company Details 13.7.2 Orexo Business Overview and Its Total Revenue 13.7.3 Orexo Opioid Use Disorder Introduction 13.7.4 Orexo Revenue in Opioid Use Disorder Business (2015-2020) 13.7.5 Orexo Recent Development 13.8 Camurus 13.8.1 Camurus Company Details 13.8.2 Camurus Business Overview and Its Total Revenue 13.8.3 Camurus Opioid Use Disorder Introduction 13.8.4 Camurus Revenue in Opioid Use Disorder Business (2015-2020) 13.8.5 Camurus Recent Development 13.9 Omeros 13.9.1 Omeros Company Details 13.9.2 Omeros Business Overview and Its Total Revenue 13.9.3 Omeros Opioid Use Disorder Introduction 13.9.4 Omeros Revenue in Opioid Use Disorder Business (2015-2020) 13.9.5 Omeros Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Opioid Use Disorder Key Market Segments Table 2. Key Players Covered: Ranking by Opioid Use Disorder Revenue Table 3. Ranking of Global Top Opioid Use Disorder Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Opioid Use Disorder Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Buprenorphine Table 6. Key Players of Methadone Table 7. Key Players of Naltrexone Table 8. Global Opioid Use Disorder Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Opioid Use Disorder Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Opioid Use Disorder Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Opioid Use Disorder Market Share by Regions (2015-2020) Table 12. Global Opioid Use Disorder Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Opioid Use Disorder Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Opioid Use Disorder Market Growth Strategy Table 18. Main Points Interviewed from Key Opioid Use Disorder Players Table 19. Global Opioid Use Disorder Revenue by Players (2015-2020) (Million US$) Table 20. Global Opioid Use Disorder Market Share by Players (2015-2020) Table 21. Global Top Opioid Use Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Use Disorder as of 2019) Table 22. Global Opioid Use Disorder by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Opioid Use Disorder Product Solution and Service Table 25. Date of Enter into Opioid Use Disorder Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Opioid Use Disorder Market Size by Type (2015-2020) (Million US$) Table 28. Global Opioid Use Disorder Market Size Share by Type (2015-2020) Table 29. Global Opioid Use Disorder Revenue Market Share by Type (2021-2026) Table 30. Global Opioid Use Disorder Market Size Share by Application (2015-2020) Table 31. Global Opioid Use Disorder Market Size by Application (2015-2020) (Million US$) Table 32. Global Opioid Use Disorder Market Size Share by Application (2021-2026) Table 33. North America Key Players Opioid Use Disorder Revenue (2019-2020) (Million US$) Table 34. North America Key Players Opioid Use Disorder Market Share (2019-2020) Table 35. North America Opioid Use Disorder Market Size by Type (2015-2020) (Million US$) Table 36. North America Opioid Use Disorder Market Share by Type (2015-2020) Table 37. North America Opioid Use Disorder Market Size by Application (2015-2020) (Million US$) Table 38. North America Opioid Use Disorder Market Share by Application (2015-2020) Table 39. Europe Key Players Opioid Use Disorder Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Opioid Use Disorder Market Share (2019-2020) Table 41. Europe Opioid Use Disorder Market Size by Type (2015-2020) (Million US$) Table 42. Europe Opioid Use Disorder Market Share by Type (2015-2020) Table 43. Europe Opioid Use Disorder Market Size by Application (2015-2020) (Million US$) Table 44. Europe Opioid Use Disorder Market Share by Application (2015-2020) Table 45. China Key Players Opioid Use Disorder Revenue (2019-2020) (Million US$) Table 46. China Key Players Opioid Use Disorder Market Share (2019-2020) Table 47. China Opioid Use Disorder Market Size by Type (2015-2020) (Million US$) Table 48. China Opioid Use Disorder Market Share by Type (2015-2020) Table 49. China Opioid Use Disorder Market Size by Application (2015-2020) (Million US$) Table 50. China Opioid Use Disorder Market Share by Application (2015-2020) Table 51. Japan Key Players Opioid Use Disorder Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Opioid Use Disorder Market Share (2019-2020) Table 53. Japan Opioid Use Disorder Market Size by Type (2015-2020) (Million US$) Table 54. Japan Opioid Use Disorder Market Share by Type (2015-2020) Table 55. Japan Opioid Use Disorder Market Size by Application (2015-2020) (Million US$) Table 56. Japan Opioid Use Disorder Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Opioid Use Disorder Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Opioid Use Disorder Market Share (2019-2020) Table 59. Southeast Asia Opioid Use Disorder Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Opioid Use Disorder Market Share by Type (2015-2020) Table 61. Southeast Asia Opioid Use Disorder Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Opioid Use Disorder Market Share by Application (2015-2020) Table 63. India Key Players Opioid Use Disorder Revenue (2019-2020) (Million US$) Table 64. India Key Players Opioid Use Disorder Market Share (2019-2020) Table 65. India Opioid Use Disorder Market Size by Type (2015-2020) (Million US$) Table 66. India Opioid Use Disorder Market Share by Type (2015-2020) Table 67. India Opioid Use Disorder Market Size by Application (2015-2020) (Million US$) Table 68. India Opioid Use Disorder Market Share by Application (2015-2020) Table 69. Central & South America Key Players Opioid Use Disorder Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Opioid Use Disorder Market Share (2019-2020) Table 71. Central & South America Opioid Use Disorder Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Opioid Use Disorder Market Share by Type (2015-2020) Table 73. Central & South America Opioid Use Disorder Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Opioid Use Disorder Market Share by Application (2015-2020) Table 75. Indivior Company Details Table 76. Indivior Business Overview Table 77. Indivior Product Table 78. Indivior Revenue in Opioid Use Disorder Business (2015-2020) (Million US$) Table 79. Indivior Recent Development Table 80. Alkermes Company Details Table 81. Alkermes Business Overview Table 82. Alkermes Product Table 83. Alkermes Revenue in Opioid Use Disorder Business (2015-2020) (Million US$) Table 84. Alkermes Recent Development Table 85. Titan Pharmaceuticals Company Details Table 86. Titan Pharmaceuticals Business Overview Table 87. Titan Pharmaceuticals Product Table 88. Titan Pharmaceuticals Revenue in Opioid Use Disorder Business (2015-2020) (Million US$) Table 89. Titan Pharmaceuticals Recent Development Table 90. Hikma Pharmaceuticals Company Details Table 91. Hikma Pharmaceuticals Business Overview Table 92. Hikma Pharmaceuticals Product Table 93. Hikma Pharmaceuticals Revenue in Opioid Use Disorder Business (2015-2020) (Million US$) Table 94. Hikma Pharmaceuticals Recent Development Table 95. Teva Pharmaceuticals Company Details Table 96. Teva Pharmaceuticals Business Overview Table 97. Teva Pharmaceuticals Product Table 98. Teva Pharmaceuticals Revenue in Opioid Use Disorder Business (2015-2020) (Million US$) Table 99. Teva Pharmaceuticals Recent Development Table 100. MediciNova Company Details Table 101. MediciNova Business Overview Table 102. MediciNova Product Table 103. MediciNova Revenue in Opioid Use Disorder Business (2015-2020) (Million US$) Table 104. MediciNova Recent Development Table 105. Orexo Company Details Table 106. Orexo Business Overview Table 107. Orexo Product Table 108. Orexo Revenue in Opioid Use Disorder Business (2015-2020) (Million US$) Table 109. Orexo Recent Development Table 110. Camurus Business Overview Table 111. Camurus Product Table 112. Camurus Company Details Table 113. Camurus Revenue in Opioid Use Disorder Business (2015-2020) (Million US$) Table 114. Camurus Recent Development Table 115. Omeros Company Details Table 116. Omeros Business Overview Table 117. Omeros Product Table 118. Omeros Revenue in Opioid Use Disorder Business (2015-2020) (Million US$) Table 119. Omeros Recent Development Table 120. Research Programs/Design for This Report Table 121. Key Data Information from Secondary Sources Table 122. Key Data Information from Primary Sources List of Figures Figure 1. Global Opioid Use Disorder Market Share by Type: 2020 VS 2026 Figure 2. Buprenorphine Features Figure 3. Methadone Features Figure 4. Naltrexone Features Figure 5. Global Opioid Use Disorder Market Share by Application: 2020 VS 2026 Figure 6. Moderate Pain Treatment Case Studies Figure 7. Severe Pain Treatment Case Studies Figure 8. Opioid Use Disorder Report Years Considered Figure 9. Global Opioid Use Disorder Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global Opioid Use Disorder Market Share by Regions: 2020 VS 2026 Figure 11. Global Opioid Use Disorder Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global Opioid Use Disorder Market Share by Players in 2019 Figure 14. Global Top Opioid Use Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Use Disorder as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Opioid Use Disorder Revenue in 2019 Figure 16. North America Opioid Use Disorder Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe Opioid Use Disorder Market Size YoY Growth (2015-2020) (Million US$) Figure 18. China Opioid Use Disorder Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Japan Opioid Use Disorder Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Southeast Asia Opioid Use Disorder Market Size YoY Growth (2015-2020) (Million US$) Figure 21. India Opioid Use Disorder Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Central & South America Opioid Use Disorder Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Indivior Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Indivior Revenue Growth Rate in Opioid Use Disorder Business (2015-2020) Figure 25. Alkermes Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Alkermes Revenue Growth Rate in Opioid Use Disorder Business (2015-2020) Figure 27. Titan Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Titan Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2015-2020) Figure 29. Hikma Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Hikma Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2015-2020) Figure 31. Teva Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Teva Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2015-2020) Figure 33. MediciNova Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. MediciNova Revenue Growth Rate in Opioid Use Disorder Business (2015-2020) Figure 35. Orexo Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Orexo Revenue Growth Rate in Opioid Use Disorder Business (2015-2020) Figure 37. Camurus Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Camurus Revenue Growth Rate in Opioid Use Disorder Business (2015-2020) Figure 39. Omeros Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Omeros Revenue Growth Rate in Opioid Use Disorder Business (2015-2020) Figure 41. Bottom-up and Top-down Approaches for This Report Figure 42. Data Triangulation Figure 43. Key Executives Interviewed

Indivior Alkermes Titan Pharmaceuticals Hikma Pharmaceuticals Teva Pharmaceuticals MediciNova Orexo Camurus Omeros